Patterns of long-term survivorship following bevacizumab treatment for recurrent glioma: a case series
Aim: Long-term survivors (LTS) after glioma recurrence while on bevacizumab (Bev) therapy are rarely reported in the current literature. The purpose of this case series is to confirm the existence of and describe a large cohort of recurrent glioma LTS treated with Bev (Bev-LTS). Patients & metho...
| Հիմնական հեղինակներ: | , , , , , , , , , , , |
|---|---|
| Ձևաչափ: | Հոդված |
| Լեզու: | English |
| Հրապարակվել է: |
Taylor & Francis Group
2019-06-01
|
| Շարք: | CNS Oncology |
| Խորագրեր: | |
| Առցանց հասանելիություն: | https://www.futuremedicine.com/doi/10.2217/cns-2019-0007 |